Corcept Therapeutics CORT Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's prepaid & other current?
- Corcept Therapeutics (CORT) reported prepaid & other current of $35.89M in Q1 2026.
- How has Corcept Therapeutics's prepaid & other current changed year-over-year?
- Corcept Therapeutics's prepaid & other current decreased by 9.3% year-over-year, from $39.55M to $35.89M.
- What is the long-term trend for Corcept Therapeutics's prepaid & other current?
- Over 5 years (2020 to 2025), Corcept Therapeutics's prepaid & other current has grown at a 43.4% compound annual growth rate (CAGR), from $6.7M to $40.66M.
- What does prepaid & other current mean?
- Payments made for future services or miscellaneous assets that will be used up within one year.
- How do you interpret prepaid & other current?
- Significant fluctuations may indicate changes in the scale of operational activities or timing of large service contracts.
- How does prepaid & other current compare across companies?
- Varies by company size and the extent of outsourced R&D or manufacturing services.